These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28398521)

  • 1. The Doctrine of Original Antigenic Sin: Separating Good From Evil.
    Monto AS; Malosh RE; Petrie JG; Martin ET
    J Infect Dis; 2017 Jun; 215(12):1782-1788. PubMed ID: 28398521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic memory to influenza A viruses in man determined by monovalent vaccines.
    Marine WM; Thomas JE
    Postgrad Med J; 1979 Feb; 55(640):98-104. PubMed ID: 461278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Original antigenic sin. A confounding issue?
    Haaheim LR
    Dev Biol (Basel); 2003; 115():49-53. PubMed ID: 15088775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Original Antigenic Sin to the Universal Influenza Virus Vaccine.
    Henry C; Palm AE; Krammer F; Wilson PC
    Trends Immunol; 2018 Jan; 39(1):70-79. PubMed ID: 28867526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses.
    Zhang A; Stacey HD; Mullarkey CE; Miller MS
    J Immunol; 2019 Jan; 202(2):335-340. PubMed ID: 30617114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines.
    Biswas A; Chakrabarti AK; Dutta S
    Int Rev Immunol; 2020; 39(1):21-36. PubMed ID: 31707873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Original antigenic sin in the influenza vaccination and its influence].
    Jiang HDC; Zhu FC
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):1070-1074. PubMed ID: 31607059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving strategies for the prevention of influenza infection: potential for multistrain targeting.
    Livingston BD; Higgins D; Van Nest G
    BioDrugs; 2006; 20(6):335-40. PubMed ID: 17176120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings.
    Worobey M; Plotkin S; Hensley SE
    Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31964642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune history and influenza virus susceptibility.
    Cobey S; Hensley SE
    Curr Opin Virol; 2017 Feb; 22():105-111. PubMed ID: 28088686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of a study of the data obtained from patients vaccinated earlier with different influenza vaccines].
    Ivanova VT; Slepushkin AN; Burtseva EI; Oskerko TA; Golubeva LI; Beliaev AL
    Vopr Virusol; 1994; 39(2):66-8. PubMed ID: 8017055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antigenic-immunogenic activity of the trivalent polymer-subunit influenza vaccine Grippol in a controlled epidemiological trial (2)].
    El'shina GA; Masalin IuM; Shervarli VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS
    Voen Med Zh; 1996 Nov; 317(11):53-5. PubMed ID: 9036633
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects for universal influenza virus vaccine.
    Gerhard W; Mozdzanowska K; Zharikova D
    Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016-2017 season.
    Ando S
    J Infect Chemother; 2018 Oct; 24(10):782-788. PubMed ID: 29945763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding original antigenic sin in influenza with a dynamical system.
    Pan K
    PLoS One; 2011; 6(8):e23910. PubMed ID: 21897863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.
    Sullivan SG; Komadina N; Grant K; Jelley L; Papadakis G; Kelly H
    J Med Virol; 2014 Jun; 86(6):1017-25. PubMed ID: 24395730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.